HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elena Cerrada Selected Research

1,3,5-triaza-7-phosphaadamantane

1/2010Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands.
7/2008Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands. X-ray crystal structures of [Au(SC4H3N2)(PTA)], trans-[Pt(SC4H3N2)2(PTA)2], trans-[Pt(SC5H4N)2(PTA)2], and trans-[Pt(SC5H4N)2(DAPTA)2].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elena Cerrada Research Topics

Disease

9Colonic Neoplasms (Colon Cancer)
06/2022 - 05/2014
8Neoplasms (Cancer)
06/2022 - 07/2008
4Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 01/2017
3Carcinoma (Carcinomatosis)
06/2022 - 11/2011
2Adenocarcinoma
12/2019 - 11/2017
2Ovarian Neoplasms (Ovarian Cancer)
06/2013 - 01/2010
1Cardiovascular Diseases (Cardiovascular Disease)
02/2021
1Mitochondrial Diseases (Mitochondrial Disease)
12/2019
1Hepatocellular Carcinoma (Hepatoma)
12/2019
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Carcinogenesis
01/2017
1Body Weight (Weight, Body)
01/2015
1Melanoma (Melanoma, Malignant)
07/2008

Drug/Important Bio-Agent (IBA)

14GoldIBA
06/2022 - 07/2008
5phosphine (phosphane)IBA
06/2022 - 01/2010
5INTERCEEDIBA
12/2021 - 05/2014
4Cisplatin (Platino)FDA LinkGeneric
06/2019 - 01/2010
4LigandsIBA
01/2019 - 01/2010
4D-Ala-peptide T-amideIBA
02/2016 - 07/2008
3Diacetyl (Biacetyl)IBA
02/2016 - 07/2008
3nonaneIBA
02/2016 - 07/2008
2PolyphenolsIBA
02/2021 - 04/2020
2PlatinumIBA
06/2019 - 07/2008
2Proteins (Proteins, Gene)FDA Link
06/2019 - 11/2017
2Pharmaceutical PreparationsIBA
01/2019 - 07/2017
21,3,5-triaza-7-phosphaadamantaneIBA
01/2010 - 07/2008
1Caspase 3 (Caspase-3)IBA
06/2022
1SulfonamidesIBA
06/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2021
1AntioxidantsIBA
02/2021
1SilverIBA
12/2020
1Plant ExtractsIBA
04/2020
1DNA (Deoxyribonucleic Acid)IBA
06/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2019
1MetalsIBA
01/2019
1ZincIBA
01/2019
1Saline SolutionIBA
09/2018
1Phosphates (Orthophosphate)IBA
09/2018
1Reducing AgentsIBA
09/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
09/2018
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2017
1Fluorouracil (Carac)FDA LinkGeneric
07/2017
1Antineoplastic Agents (Antineoplastics)IBA
07/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Long Noncoding RNAIBA
01/2017
1MicroRNAs (MicroRNA)IBA
01/2017
1Alkynes (Acetylenes)IBA
02/2016
1triphenylphosphineIBA
01/2010
1ThioredoxinsIBA
01/2010
1Oxidoreductases (Dehydrogenase)IBA
01/2010
1SodiumIBA
01/2010
1EnzymesIBA
01/2010
12-thiopyridineIBA
07/2008
1P-2 (P 2)IBA
07/2008

Therapy/Procedure

2Therapeutics
12/2019 - 06/2019
1Drug Therapy (Chemotherapy)
06/2019